>

Rimsys secures $5 million in growth financing round

By
Bethaney Lentz
-
September 30, 2024
Rimsys secures $5 million in growth financing round

Rimsys recently secured $5 million in a growth financing round from Global Opportunity Pennsylvania Fund II, L.P. (GO PA Fund), Riverfront Ventures, and existing investor, Innovation Works. GO PA Fund, Riverfront Ventures, and Innovation Works have a strong commitment to fostering innovation and creativity in Pennsylvania, which makes them great financial partners for Rimsys.

“We’re ecstatic to have support from GO PA Fund, Riverfront, and existing investors as we enter a new growth phase at Rimsys,” said James Gianoutsos, Rimsys Founder and CEO. “Our next phase of growth builds on our mission to increase accessibility to life-changing medical technologies with a focus on regulatory intelligence, submissions management, and UDI enhancements and thoughtfully incorporating advanced technologies like AI into our roadmap to meet growing demand and changing global regulatory requirements. We are grateful to work with firms that are committed to nurturing innovation in the Pittsburgh region, which has given so much opportunity to us.”

Our growth financing will help ensure that Rimsys provides a world-class, unified regulatory information management (RIM) solution for the medtech industry and that it meets the challenges that come with a frequently evolving regulatory landscape.

Those interested in learning more can read the press release from GO PA Fund and a recent Post-Gazette interview with our founder, James Gianoutsos:


ABOUT GO PA FUND

Formed by Ben Franklin Technology Partners of Southeastern Pennsylvania, with collaboration from Ben Franklin of Northeastern Pennsylvania, Ben Franklin of Central and Northern Pennsylvania, and Innovations Works from Southwestern Pennsylvania, the GO PA Fund invests in technology-based ventures throughout the Commonwealth of Pennsylvania. The GO PA Fund primarily invests as a follow-on fund to companies selected from Ben Franklin’s statewide portfolio of more than 600 burgeoning ventures throughout Pennsylvania. The Fund leverages Ben Franklin’s best-in-class multi-year/multi-round due diligence to ensure access to qualified and vetted opportunities while minimizing costs of investment. Visit us at gopafund.com.

ABOUT BEN FRANKLIN TECHNOLOGY PARTNERS OF SOUTHEASTERN PENNSYLVANIA

Ben Franklin Technology Partners of Southeastern Pennsylvania (“Ben Franklin”) is the Philadelphia region’s Partners with a Purpose. Nationally ranked among the most active seed and early-stage investors, Ben Franklin helps high-growth innovative enterprises plant and nurture their roots, creating both immediate connections and lasting economic growth. The nonprofit has supported more than 2,000 companies to deliver an impact of more than $5 billion and 32,000 jobs in the Philadelphia region. Whether in tech, life sciences, manufacturing, or industries and breakthroughs yet discovered, Ben Franklin works to raise the community of innovation higher, to benefit present and future generations of Pennsylvanians. Visit us at partnerswithapurpose.org, or follow us at @bftp_sep.

ABOUT INNOVATION WORKS

Innovation Works is one of the most active early-stage investors in the country and the most active in Pennsylvania. Since its inception of the seed fund in 1999, Innovation Works has invested in over 760 companies that have gone on to raise $3.3 billion in follow-on funding. Portfolio companies have generated and retained over 20,000 jobs in Pennsylvania. Innovation Works is part of the Ben Franklin Technology Partners network, which has catalyzed economic growth over the last 30 years by providing access to capital and networks that help foster innovation and technology-based economic development in Pennsylvania. Learn more at innovationworks.org.

ABOUT RIVERFRONT VENTURES

Riverfront Ventures is an early-stage venture capital fund based in Pittsburgh, PA focused on investing in early-growth stage tech companies. Learn more at riverfrontventures.com.

ABOUT RIMSYS

Rimsys is improving global health by accelerating delivery and increasing availability of life-changing medical technologies. Rimsys Regulatory Information Management (RIM) software digitizes and automates regulatory activities, helping medtech regulatory affairs teams to plan more effectively, execute more quickly, and confidently ensure global regulatory compliance.  Rimsys is designed around medtech workflows and supports a full breadth of regulatory activities including registrations, submissions, UDI, essential principles, and standards management in a single, integrated platform. For more information, visit www.rimsys.io.

Similar posts

Insights from the Gens and Associates Executive Podcast with James Gianoutsos
Insights from the Gens and Associates Executive Podcast with James Gianoutsos
FDA’s Final Rule on LDTs: What manufacturers need to know
FDA’s Final Rule on LDTs: What manufacturers need to know
 Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech